Log In
BCIQ
Print this Print this
 

BonyPid-500

  Manage Alerts
Collapse Summary General Information
Company PolyPid Ltd.
DescriptionSynthetic, doxycycline eluting bone graft substitute based on beta Tricalcium phosphate granules
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationBone repair
Indication DetailsReconstruct bone defects caused by peri-implantitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today